Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken. (Q37084269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

main subject

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Dimitrios N Samonakis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Nikolaos Christodoulakis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Elias A Kouroumalis

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

14 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

2359-2365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-007-0175-9

2 January 2020

exact match

0 references

cites work

Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-007-0175-9

Hepatocellular carcinoma: present status and future prospects

21 January 2018

1 reference

12 December 2020

Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.

1 reference

12 December 2020

Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide

1 reference

12 December 2020

Oncological applications of somatostatin analogues

1 reference

12 December 2020

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

12 December 2020

The role of somatostatin analogs in the control of tumor growth.

1 reference

12 December 2020

Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells

1 reference

12 December 2020

Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma

1 reference

12 December 2020

Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype

1 reference

12 December 2020

Primary liver cancer: worldwide incidence and trends

1 reference

12 December 2020

Regulatory peptide receptors in human hepatocellular carcinomas

1 reference

12 December 2020

1 reference

12 December 2020

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

12 December 2020

Octreotide therapy for advanced hepatocellular carcinoma

1 reference

12 December 2020

Regulation and function of somatostatin receptors

1 reference

12 December 2020

The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors

1 reference

12 December 2020

Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238.

1 reference

12 December 2020

Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells

1 reference

12 December 2020

Octreotide for unresectable hepatocellular carcinoma: beyond the first sight.

1 reference

12 December 2020

Liver transplantation in patients with hepatocellular carcinoma

1 reference

12 December 2020

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

12 December 2020

Octreotide treatment of hepatocellular carcinoma

1 reference

12 December 2020

Treatment of hepatocellular carcinoma with long acting somatostatin analogues.

1 reference

12 December 2020

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

12 December 2020

Somatostatin analogs in the diagnosis and treatment of cancer

1 reference

12 December 2020

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

1 reference

12 December 2020

Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study.

1 reference

12 December 2020

Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo

1 reference

12 December 2020

Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma

1 reference

12 December 2020

A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.

1 reference

12 December 2020

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium

1 reference

12 December 2020

Hepatocellular carcinoma: current surgical management

1 reference

12 December 2020

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma: the need for progress.

1 reference

12 December 2020

Signal transduction of somatostatin receptors negatively controlling cell proliferation.

1 reference

12 December 2020

Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: a possible anti-tumour mechanism.

1 reference

12 December 2020

Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage

1 reference

12 December 2020

Complete regression of advanced HCC with long acting octreotide

1 reference

12 December 2020

Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors

1 reference

12 December 2020

Somatostatin and its receptor family

1 reference

12 December 2020

Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas.

1 reference

12 December 2020

Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis

1 reference

12 December 2020

Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma

1 reference

12 December 2020

The pathophysiological consequences of somatostatin receptor internalization and resistance

1 reference

12 December 2020

Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum

1 reference

12 December 2020

A dramatic response to long-acting octreotide in metastatic hepatocellular carcinoma

1 reference

12 December 2020

Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.

1 reference

12 December 2020

Somatostatin receptors and regulation of cell proliferation

1 reference

12 December 2020

Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma

1 reference

12 December 2020

The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.

1 reference

12 December 2020

Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotide

1 reference

12 December 2020

Treatment outcomes with long acting octreotide in inoperable hepatocellular carcinoma: a local experience and review of literature.

1 reference

12 December 2020

Review article: hepatocellular carcinoma: indications for liver transplantation

1 reference

12 December 2020

10.1007/S10620-007-0175-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference